Call for Your FREE Evaluation (877) 503-1595


Areas of Practice

Get a FREE Evaluation

By submitting this form you agree to be contacted by affiliates and/or attorneys regarding your claim. You consent to contacting you through the use of text message, phone call, and electronic mail message even if your number is a wireless number or if I am presently listed on a Do Not Call list. My consent does not require purchase.

Call for your FREE consultation with a personal attorney: (877) 503-1595


Johnson & Johnson has scored a victory in the Levaquin litigation it has been fighting.  A United States Court of Appeals ruled for the drug giant, reversing a $1.1 million punitive award that a jury had awarded to plaintiff John Schedin.

The Court of Appeals states that there was no evidence that Johnson & Johnson deliberately disregarded the safety of Levaquin users.  They left a compensatory award of $630,000 in tact.

Johnson & Johnson has faced more than 3,400 state and federal lawsuits alleging that use of the antibiotic Levaquin led to severe tendon damage and rupture in many patients.  Last month J&J settled over 800 cases.  Of the four cases that have gone to trial, J&J has won three of them, and the fourth that was lost is the Schedin case.

In 2008, the FDA added a black box warning to Levaquin, the most serious type of warning a drug can carry.  The lawsuits against Levaquin allege that patients taking the drug face increased risk of tendon rupture, damage and tendonitis, which can leave patients permanently disabled.